News by Year - 2023

Pune : HIV infected people will get TB treatment from six months to a month

Post Date: 
2023-12-16
Source: 
Pune Mirror
Team photo
Director Dr. Nishi Suryavanshi, said, “One to Three HP' trial will generate scientific evidence for ultra-short-term TB preventive regimens. This may improve the TB prevention guideline system and policy in India. In turn, this study will help expand medical research on TB-HIV.

World AIDS Day 2023

Post Date: 
2023-12-14
Pune Team
For World AIDS Day, BJGMC CRS), Pune, hosted a discussion on six major HIV related studies.

NIH clinical trial of tuberculous meningitis drug regimen begins

Post Date: 
2023-12-07
Source: 
NIH
Tuberculosis bacteria
The Improved Management with Antimicrobial Agents Isoniazid Rifampicin Linezolid for TBM (IMAGINE-TBM) trial will compare a six-month regimen of four drugs with the nine-month, standard-of-care regimen for TBM.

Photo from the Union Conference 2023

Post Date: 
2023-11-21
CIDI team at a table
Check out the photo gallery from CIDI at the 2023 Union Conference on Lung Health.

Common antibiotic can prevent drug-resistant TB in exposed kids, says study. But is it safe?

Post Date: 
2023-11-20
Source: 
Indian Express
Vidya Mave with text quote
Two clinical trials show how Levofloxacin, given once daily to children over six months, prevented infection in five-year-olds exposed to MDR-TB by 56 per cent and in adolescents by 45 per cent.

CIDI at the Union 2023

Post Date: 
2023-11-09
Union 2023 Conference
CIDI was in Paris for The Union Conference on Lung Health 2023! Check out what CIDI faculty and Johns Hopkins India Partners spoke about at the sessions listed!

New study aims for best strategy to find recurrent cases of Tuberculosis

Post Date: 
2023-09-15
Source: 
Indian Express
Counsellors visit patients ' homes
A novel trial is underway in Pune to provide evidence on how best to find people with recurrent Tuberculosis (TB) , so that they can be quickly linked to care.

Navigating Adolescence With HIV

Post Date: 
2023-09-06
Source: 
Span Magazine
USAID-supported Adolescent-Friendly Health Centers create a supportive youth-led community that can help HIV positive children navigate challenges. (Photograph courtesy ACCELERATE)
USAID, with support of PEPFAR , set up Adolescent-Friendly Health Centers through its flagship program, ACCELERATE, led by Johns Hopkins University School of Medicine, to support 10-17-year-old HIV positive adolescents with comprehensive health care and services.

Making HIV Care Accessible

Post Date: 
2023-09-06
Source: 
Span Magazine
TAAL (Treatment, Adherence, Advocacy and Literacy) was launched in 2006, as a peer-led community pharmacy to provide high-quality and affordable HIV diagnostics, treatment and peer counseling services to people living with HIV. In 2020, with support from USAID, TAAL transitioned from a community...

Turning the Tide for HIV-Affected Families

Post Date: 
2023-09-06
Source: 
Span Magazine
The orphans and vulnerable children program—which serves children and adolescents who are at risk of infection, live with HIV or with HIV-positive caregivers—provide peer-led and family-centric care. One such USAID project, ACCELERATE , implemented by John Hopkins University, works closely with...

Taking HIV Care Online

Post Date: 
2023-09-06
Source: 
Span Magazine
A sexual health manager at Safe Zindagi explains the HIV self-testing process to a client. (Photograph courtesy Safe Zindagi)
Safe Zindagi , an online portal funded by USAID and PEPFAR, provides HIV care and services to hard-to-reach populations in India.

Pune study shows ‘promising results’ in bid to prevent TB among those at most risk

Post Date: 
2023-08-01
Source: 
Indian Express
Woman showing a diagram to a patient
Interim results are “promising” and show that a short treatment regimen called “3HP” could pave the way in preventing TB.

How a Pune trial SHINEs light on shorter TB treatment for children

Post Date: 
2023-06-26
Source: 
The Indian Express
TB OPD at Sassoon hospital
Last year, based on SHINE research, the WHO strongly recommended shortening the TB treatment duration in non-severe paediatric TB cases from six-four months.

Paediatric TB: An Overview (India)

Post Date: 
2023-06-26
Source: 
Survivors Against TB
Paediatric TB: An Overview (India)
Video: Shedding Light on Pediatric TB in India

Research shows India can shorten tuberculosis treatment

Post Date: 
2023-06-13
Source: 
The Hindu
Vidya Mave and Aarti Kinikar with text
Recent studies have found that the length of time tuberculosis patients need to stay on their regimen can be reduced from six to four months.

Pride & Beyond: Addressing Health Equity for LGBTQIA+ People in India

Post Date: 
2023-06-08
Source: 
CIDI
Mitr Clinic team
On Wednesday, June 7th, CIDI celebrated Pride Month at the event "Pride & Beyond: Addressing Health Equity for LGBTQIA+ People in India."

Suniti Solomon: India’s Preeminent HIV Researcher & Activist

Post Date: 
2023-05-31
Suniti Solomon
Dr. Suniti Solomon detected India’s first cases of HIV. She also founded YRG CARE & raised CIDI Co-director Dr. Sunil Solomon. Learn about her commitment to science & unwavering dedication to compassionate patient care.

India Research Partnership Commemorates World TB Day

Post Date: 
2023-04-14
Group Photo
World TB Day event in Pune includes a special street play, counseling sessions, and research and education discussions, aimed to engage the community in healthy approaches to TB treatment and prevention under this year’s World TB Day theme "Yes we can end TB."

Daily statin reduces the risk of cardiovascular disease in people living with HIV, large NIH study finds

Post Date: 
2023-04-12
A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this...

Clone of Daily statin reduces the risk of cardiovascular disease in people living with HIV, large NIH study finds

Post Date: 
2023-04-12
A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this...

Pages